Succinylcholine, malignant hyperthermia and rhabdomyolysis

CMAJ. 2022 Jun 27;194(25):E878. doi: 10.1503/cmaj.146480-l.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Humans
  • Malignant Hyperthermia* / diagnosis
  • Malignant Hyperthermia* / etiology
  • Malignant Hyperthermia* / therapy
  • Rhabdomyolysis* / diagnosis
  • Rhabdomyolysis* / etiology
  • Rhabdomyolysis* / therapy
  • Succinylcholine / adverse effects

Substances

  • Succinylcholine